1. Home
  2. NKTR vs EPSN Comparison

NKTR vs EPSN Comparison

Compare NKTR & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • EPSN
  • Stock Information
  • Founded
  • NKTR 1990
  • EPSN 2005
  • Country
  • NKTR United States
  • EPSN Canada
  • Employees
  • NKTR N/A
  • EPSN N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • EPSN Oil & Gas Production
  • Sector
  • NKTR Health Care
  • EPSN Energy
  • Exchange
  • NKTR Nasdaq
  • EPSN Nasdaq
  • Market Cap
  • NKTR 160.4M
  • EPSN 153.4M
  • IPO Year
  • NKTR 1994
  • EPSN N/A
  • Fundamental
  • Price
  • NKTR $0.59
  • EPSN $6.77
  • Analyst Decision
  • NKTR Strong Buy
  • EPSN Strong Buy
  • Analyst Count
  • NKTR 6
  • EPSN 1
  • Target Price
  • NKTR $4.92
  • EPSN $7.00
  • AVG Volume (30 Days)
  • NKTR 2.3M
  • EPSN 44.6K
  • Earning Date
  • NKTR 05-08-2025
  • EPSN 05-14-2025
  • Dividend Yield
  • NKTR N/A
  • EPSN 3.69%
  • EPS Growth
  • NKTR N/A
  • EPSN N/A
  • EPS
  • NKTR N/A
  • EPSN 0.09
  • Revenue
  • NKTR $87,248,000.00
  • EPSN $31,522,775.00
  • Revenue This Year
  • NKTR N/A
  • EPSN $41.35
  • Revenue Next Year
  • NKTR N/A
  • EPSN N/A
  • P/E Ratio
  • NKTR N/A
  • EPSN $77.01
  • Revenue Growth
  • NKTR N/A
  • EPSN 2.58
  • 52 Week Low
  • NKTR $0.43
  • EPSN $4.95
  • 52 Week High
  • NKTR $1.93
  • EPSN $7.32
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 39.04
  • EPSN 49.92
  • Support Level
  • NKTR $0.57
  • EPSN $6.33
  • Resistance Level
  • NKTR $0.81
  • EPSN $7.28
  • Average True Range (ATR)
  • NKTR 0.06
  • EPSN 0.29
  • MACD
  • NKTR -0.01
  • EPSN -0.04
  • Stochastic Oscillator
  • NKTR 7.48
  • EPSN 45.83

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About EPSN Epsilon Energy Ltd. Common Share

Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.

Share on Social Networks: